Surgery Partners, Inc. (NASDAQ:SGRY) Receives $43.13 Consensus Price Target from Brokerages

Shares of Surgery Partners, Inc. (NASDAQ:SGRYGet Free Report) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $43.13.

A number of research analysts recently issued reports on the company. Citigroup decreased their price objective on Surgery Partners from $42.00 to $38.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. StockNews.com upgraded Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, March 21st. Royal Bank of Canada restated an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a research note on Thursday, February 29th. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research note on Wednesday, April 10th. Finally, Benchmark restated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Wednesday, May 1st.

Check Out Our Latest Research Report on SGRY

Surgery Partners Trading Up 2.0 %

Shares of SGRY opened at $27.28 on Tuesday. Surgery Partners has a 12-month low of $22.05 and a 12-month high of $45.79. The stock’s fifty day simple moving average is $26.30 and its 200-day simple moving average is $29.94. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $3.47 billion, a PE ratio of 29.69, a price-to-earnings-growth ratio of 2.02 and a beta of 2.75.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The firm had revenue of $717.40 million for the quarter, compared to analyst estimates of $707.66 million. As a group, research analysts predict that Surgery Partners will post 0.84 earnings per share for the current year.

Insider Activity

In other news, CEO Jason Eric Evans sold 1,984 shares of Surgery Partners stock in a transaction on Monday, March 11th. The stock was sold at an average price of $29.44, for a total value of $58,408.96. Following the transaction, the chief executive officer now owns 464,510 shares in the company, valued at approximately $13,675,174.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.

Hedge Funds Weigh In On Surgery Partners

Several hedge funds and other institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC grew its position in Surgery Partners by 69.7% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company’s stock worth $86,000 after acquiring an additional 1,210 shares during the last quarter. Signaturefd LLC bought a new stake in Surgery Partners during the 3rd quarter worth $56,000. Assenagon Asset Management S.A. grew its position in Surgery Partners by 132.9% during the 3rd quarter. Assenagon Asset Management S.A. now owns 32,657 shares of the company’s stock worth $955,000 after acquiring an additional 18,638 shares during the last quarter. Jump Financial LLC grew its position in Surgery Partners by 162.4% during the 3rd quarter. Jump Financial LLC now owns 16,229 shares of the company’s stock worth $475,000 after acquiring an additional 10,043 shares during the last quarter. Finally, Barclays PLC grew its position in Surgery Partners by 204.9% during the 3rd quarter. Barclays PLC now owns 289,663 shares of the company’s stock worth $8,472,000 after acquiring an additional 194,658 shares during the last quarter.

About Surgery Partners

(Get Free Report

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Recommended Stories

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.